These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1858386)

  • 1. [New special drugs registered in Austria. Losec (omeprazole)].
    Farr C; Georgieff GS
    Wien Klin Wochenschr; 1991; 103(11):343-8. PubMed ID: 1858386
    [No Abstract]   [Full Text] [Related]  

  • 2. Omeprazole.
    Gazzard BG
    Br J Clin Pract; 1989 Nov; 43(11):408-11. PubMed ID: 2611096
    [No Abstract]   [Full Text] [Related]  

  • 3. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
    Harewood G
    N Engl J Med; 1999 Oct; 341(18):1398; author reply 1398-9. PubMed ID: 10577093
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of pharmacologically altered gastric pH on cadmium absorption from the diet and its accumulation in murine tissues.
    Waisberg M; Black WD; Chan DY; Hale BA
    Food Chem Toxicol; 2005 May; 43(5):775-82. PubMed ID: 15778018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole: a new approach to gastric acid suppression.
    Buhl K; Clearfield HR
    Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bioavailability of two enteric-coated capsules of omeprazole in healthy volunteers.
    Garg SK; Chugh Y; Tripathi SK; Kumar N; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):96-9. PubMed ID: 8458683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings of the International Symposium on Omeprazole. Monte-Carlo, Monaco, 11-12 November 1988.
    Scand J Gastroenterol Suppl; 1989; 166():1-184. PubMed ID: 2602910
    [No Abstract]   [Full Text] [Related]  

  • 8. [Omeprazole].
    Isal JP
    Gastroenterol Clin Biol; 1987 Nov; 11(11):768-80. PubMed ID: 3322924
    [No Abstract]   [Full Text] [Related]  

  • 9. [A relative bioavailability study of 2 oral formulations of omeprazole after their administration in repeated doses to healthy volunteers].
    Richards JP; Gimeno M; Moreland TA; McEwen J
    Gastroenterol Hepatol; 1999 Apr; 22(4):171-5. PubMed ID: 10349786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole.
    Cheung G
    Conn Med; 1990 Jul; 54(7):392-3. PubMed ID: 2394098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: similarities and differences among delayed-release proton-pump inhibitor formulations.
    Horn JR; Howden CW
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():20-4. PubMed ID: 16303033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole and the metabolism of caffeine.
    Andersson T; Eriksson S; Walan A; Hässle A
    Am J Gastroenterol; 1995 Mar; 90(3):515-8. PubMed ID: 7726975
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rational posology and drug dosage].
    Riant P; Albengres E; Barre J; Tillement JP
    Ann Biol Clin (Paris); 1986; 44(1):15-24. PubMed ID: 3518550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of H+, K+-ATP-ase inhibitors. Proceedings of a symposium. Maastricht, November 25, 1988.
    Digestion; 1989; 44 Suppl 1():1-95. PubMed ID: 2606279
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioequivalence study of two capsule formulations of omeprazole.
    Pillai GK; Salem MS; Najib NM; Jilani J; Hasan MM; Ghanem E; Sallam E; Shubair MS; al-Delq S
    Acta Pharm Hung; 1996 Nov; 66(6):231-5. PubMed ID: 9604487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vision and hearing disorders with omeprazole: the facts].
    Labenz J; Stolte M
    Leber Magen Darm; 1995 Jan; 25(1):6-8, 11. PubMed ID: 7877431
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic changes in critical illness.
    Boucher BA; Wood GC; Swanson JM
    Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: immediate-release proton-pump inhibitor therapy--potential advantages.
    Howden CW
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():25-30. PubMed ID: 16303034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience in the use of losek (omeprazole) in gastroenterology].
    Maev IV; V'iuchnova ES; Lebedev EG; Dicheva DT; Ovsiannikova EV; Antonenko OM; Shchekina MI
    Ter Arkh; 2001; 73(7):79-82. PubMed ID: 11523419
    [No Abstract]   [Full Text] [Related]  

  • 20. Omeprazole: short- and long-term safety.
    Yeomans ND
    Adverse Drug React Toxicol Rev; 1994; 13(3):145-56. PubMed ID: 7827223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.